Big Pharma — International Commission on the Clinical Use of Human Germline Genome Editing

Report from the International Commission on the Clinical Use of Human Germline Genome Editing  Hear from the co-chairs and commissioners of the International Commission on the Clinical Use of Human Germline Genome Editing as they launch their report defining a responsible pathway for the clinical use of heritable human genome editing, should a decision be made by any nation to permit its use. The Commission was formed in the aftermath of the 2018 International Summit on Human Genome Editing held in Hong Kong, where a researcher from China announced that twins had been born following editing he had performed on...